BioNTech SE (BNTX) Long-Term Debt Repayments (2019 - 2025)

BioNTech SE (BNTX) has 7 years of Long-Term Debt Repayments data on file, last reported at -$10.0 million in Q4 2025.

• For the quarter ending Q4 2025, Long-Term Debt Repayments changed N/A year-over-year to -$10.0 million; the trailing twelve-month figure through Dec 2025 stood at -$20.3 million (up 99.29% YoY), and the FY2025 full-year result was -$20.3 million, down 727.44% from the prior year.
• Long-Term Debt Repayments declined to -$10.0 million in Q4 2025, from -$1.4 million in the prior quarter.
• In the past five years, Long-Term Debt Repayments ranged from a high of $1.8 billion in Q4 2023 to a low of -$2.9 billion in Q1 2024.
• A 5-year average of -$194.5 million and a median of -$2.5 million in 2024 frame the typical range for Long-Term Debt Repayments.
• Across the five-year window, Long-Term Debt Repayments tumbled 2498912357.2% in 2022 and soared 99.83% in 2025, its largest moves.
• Tracing BNTX's Long-Term Debt Repayments over 5 years: stood at -$58.0 in 2021, then sank by 32682274.62% to -$19.0 million in 2022, then jumped by 9772.67% to $1.8 billion in 2023, then tumbled by 100.14% to -$2.5 million in 2024, then tumbled by 304.18% to -$10.0 million in 2025.
• Business Quant data shows BNTX's Long-Term Debt Repayments at -$10.0 million in Q4 2025, -$1.4 million in Q3 2025, and -$4.2 million in Q2 2025.